NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
(Total Views: 191)
Posted On: 06/28/2018 6:24:41 PM
NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Innovative Therapies as Alternative Medicine Market Surges
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing pioneering options for preventive and curative therapies by utilizing several creative pathways. An article further discussing the company reads: “Chronic diseases and recurring health care issues are taking an increasingly bigger piece of the economic pie and disrupting the lives of many millions of people. U.S. health care costs for chronic diseases totaled $1.1 trillion in 2016 and balloon to $3.7 trillion when lost economic productivity is calculated into the total economic impact. According to a new report by Grand View Research, people around the world, along with their governments, are starting to take notice of alternative medicines and forms of therapy for chronic ailments and long-term pain (http://nnw.fm/y2GXP). The complementary and alternative medicine market is expected to generate revenue of more than $196 billion by 2025, the report states. … PreveCeutical is dedicated to developing preventative medical therapies based on the recognized health benefits of natural substances. A key component of its research and development program is the development of its sustained-release Sol-gel drug delivery platform, which would allow CBD-based therapies to become optimally bioavailable to patients dealing with a wide range of debilitating conditions.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing pioneering options for preventive and curative therapies by utilizing several creative pathways. An article further discussing the company reads: “Chronic diseases and recurring health care issues are taking an increasingly bigger piece of the economic pie and disrupting the lives of many millions of people. U.S. health care costs for chronic diseases totaled $1.1 trillion in 2016 and balloon to $3.7 trillion when lost economic productivity is calculated into the total economic impact. According to a new report by Grand View Research, people around the world, along with their governments, are starting to take notice of alternative medicines and forms of therapy for chronic ailments and long-term pain (http://nnw.fm/y2GXP). The complementary and alternative medicine market is expected to generate revenue of more than $196 billion by 2025, the report states. … PreveCeutical is dedicated to developing preventative medical therapies based on the recognized health benefits of natural substances. A key component of its research and development program is the development of its sustained-release Sol-gel drug delivery platform, which would allow CBD-based therapies to become optimally bioavailable to patients dealing with a wide range of debilitating conditions.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)PreveCeutical Medical Inc. (PRVCF) Stock Research Links
Scroll down for more posts ▼